"Bioimpedance Spectroscopy Reduces Progression of Breast Cancer-Related Lymphedema" - John DeRosier
Post-treatment surveillance with bioimpedance spectroscopy — which uses an electric current to measure intercellular fluid volume — reduced progression of breast cancer-related lymphedema requiring complex decongestive physiotherapy compared with conventional tape measure assessment, according to results of a randomized study presented at American Society of Breast Surgeons Annual Meeting. According to Paul Schmidt, MD, PhD, associate professor of surgery at the Icahn School of Medicine at Mount Sinai who was not involved in the study, “It is too early to say whether this will change the standard of surveillance for women at risk for breast cancer-related lymphedema. The results of this study are encouraging, and they corroborate other data we have that show the importance of early intervention and prospective screening for early evidence of lymphedema.”
— Paul H. Schmidt, MD, PhD, Associate Professor, Surgery, Icahn School of Medicine at Mount Sinai, Director, Cancer Risk Program, Dubin Breast Center, Mount Sinai Health System